Tocilizumab in the treatment of rheumatoid arthritis and beyond
Nadera Sweiss(University of Illinois Chicago), David W. Perkins(University of Illinois Chicago), Munir Shawagfeh(King Hussein Cancer Center), Shiva Arami(University of Illinois Chicago), William Swedler(University of Illinois Chicago), Rebekah L. Hanson(University of Illinois Chicago), Shiva Shahrara(University of Illinois Chicago), Sameer Smadi(King Hussein Medical Center), Abdel Naser Shunaigat(King Hussein Medical Center), Ray Sawaqued(Methodist Hospital), Suncica Volkov(University of Illinois Chicago), Peter Korsten(Universitätsmedizin Göttingen), Anjali Shetty(University of Illinois Chicago), Olga M Vila(University of Illinois Chicago)
Cited by 107
Related Papers
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
|Circulation Cardiovascular Imaging|2016|217